What a Selank protocol is claiming when it cites a foreign approval
For nearly every compound this site covers, a printed provider protocol has nothing behind it but animal work. Here there is a genuine foreign registration standing in the background, and it gets used as though it were a warrant for the page in your hand. It is not, and the reasons are worth setting out carefully.
Look closely at what a citation like that establishes. It establishes that a national regulator, in one country, assessed a dossier and permitted a specific manufactured product to be sold for a defined use.
It does not establish that the compound is approved where you are. There is no FDA, EMA or MHRA authorisation. It does not establish that the preparation your provider will supply is the licensed product, and it almost certainly is not. It does not establish an indication for the reason you are being offered it, since approval is always for a defined use rather than for a molecule in general. And it does not establish that the amount, interval or duration on the page came from anywhere except the person who wrote it.
So a true sentence about approval abroad is compatible with a document that has no local authority at all. The sentence is not a lie. It is a piece of borrowed credibility, and the borrowing happens in the reader's head rather than on the page.
What a Western provider is actually working from
Consider the position honestly. A clinician here who offers this compound cannot prescribe the licensed Russian product, cannot rely on a local label because none exists, and cannot cite a Western trial because there is no genuine registered one. What they have is a foreign registration they cannot dispense under, a body of clinical literature published largely in Russian and not indexed with the records an English speaking reader would search, animal work in rats and mice, and their own clinical judgment.
That is not nothing, and it is not what a protocol format implies. The format implies a plan derived from an established treatment standard. The reality is a plan assembled from sources that were never intended to produce one, for a product whose contents nobody has verified.
None of this requires the provider to be acting badly. Most are not. The document simply carries more implied authority than its inputs support, and the person receiving it has no easy way to see the difference.
What a well formatted page cannot create
Detail and support are unrelated properties. A protocol can specify an amount to a decimal place and a schedule to the day while the underlying local evidence remains absent, and the precision then reads as rigour rather than reporting it.
Here is the record in plain form. This is a synthetic heptapeptide derived from tuftsin, developed in Russia, studied mainly as an anxiolytic, registered as a medicine there. Human clinical work exists within that system. Animal behavioural work exists in rats and mice. No Western regulator has authorised it and no genuine Western trial is registered, which means no protocol printed in London or Los Angeles can point to a local result.
A page cannot change that by being well formatted. If it cites the foreign approval, ask what the citation is doing: it is describing a different product in a different system, offered to different patients under different accountability.
Two kinds of monitoring, and which one you are getting
Protocols usually promise follow up, and follow up sounds like safety. Two different things go by that name.
Inside a regulated system, monitoring is layered. A prescriber watches an individual patient, and above that sits a national reporting scheme collecting adverse events across the whole population using the product. That second layer is what catches harms too rare or too slow for any single practice to notice, and it can trigger a label change or a withdrawal.
A provider protocol offers only the first layer, and a narrower version of it. One practice sees its own patients, has no obligation to report anything to a national scheme, and no scheme exists to receive reports about an unapproved research chemical anyway. A review appointment is genuinely useful for the person in the chair. It is not surveillance, and describing it as monitoring imports a meaning it has not earned.
Where the professional setting does its work
Some of what a clinic provides is real and worth paying for. Screening for conditions that make the whole idea unwise. Reviewing existing prescriptions, which matters for anything acting on mood or the nervous system. Asking whether an anxiety complaint has a cause deserving investigation rather than a compound. Taking responsibility for the encounter.
The trouble is that those genuine services sit in the same room as the unearned claim, and the room does not distinguish between them. A consumer reasonably infers that a substance discussed in a clinical setting has been through the process that produces clinical settings. For this compound, in this jurisdiction, it has not.
Separating the two is the practical skill. Judgment about you can be excellent while the regulatory position of the compound stays exactly where it was.
Three checks to run on a document that cites the foreign licence
The citation is the most persuasive element on the page, so it is worth handling deliberately rather than letting it pass.
Check what product the licence covers, then ask which product you will receive. If the answer is not the licensed preparation, and it will not be, the citation describes something you are not being given. That single question does more work than any argument about evidence.
Check what the licence is for. Approvals are granted for defined indications in defined populations. If the reason you are being offered the compound is not that indication, the approval is being cited in support of a use it never covered, which is a different claim wearing the same reference.
Check what the document says about where its numbers came from. A protocol that cites a foreign approval and then states an amount is implying, without asserting, that one produced the other. Asking directly whether the figure is taken from that label, adapted from it, or estimated is a fair question, and the answer tells you how the whole page was assembled.
None of these requires technical knowledge. They require reading the citation as a claim rather than as a credential.